Basildon and Thurrock University Hospitals NHS Foundation Trust   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: United Kingdom (2004)

Organization Overview

First Clinical Trial
2013
NCT01882179
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Basildon and Thurrock University Hospitals | Basildon and Thurrock University Hospitals NHS Foundation Trust

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 3)

Cerebral Hemorrhage (Phase 3)

Hemorrhage (Phase 3)

Infarction (Phase 3)

Multiple Sclerosis (Phase 2)

Myocardial Infarction (Phase 3)

Reperfusion Injury (Phase 3)

Sclerosis (Phase 2)

ST Elevation Myocardial Infarction (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 6